229 related articles for article (PubMed ID: 12372927)
1. Prospective assessment of a nomogram for the initiation of oral anticoagulation therapy for outpatient treatment of venous thromboembolism.
Kovacs MJ; Anderson DA; Wells PS
Pathophysiol Haemost Thromb; 2002; 32(3):131-3. PubMed ID: 12372927
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial.
Kovacs MJ; Rodger M; Anderson DR; Morrow B; Kells G; Kovacs J; Boyle E; Wells PS
Ann Intern Med; 2003 May; 138(9):714-9. PubMed ID: 12729425
[TBL] [Abstract][Full Text] [Related]
3. Warfarin initiation nomograms for venous thromboembolism.
Garcia P; Ruiz W; Loza Munárriz C
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD007699. PubMed ID: 26822633
[TBL] [Abstract][Full Text] [Related]
4. Outpatient management of anticoagulation therapy.
du Breuil AL; Umland EM
Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618
[TBL] [Abstract][Full Text] [Related]
5. Warfarin initiation nomograms for venous thromboembolism.
Garcia P; Ruiz W; Loza Munarriz C
Cochrane Database Syst Rev; 2013 Jul; (7):CD007699. PubMed ID: 23839808
[TBL] [Abstract][Full Text] [Related]
6. A 10 mg warfarin initiation nomogram is safe and effective in outpatients starting oral anticoagulant therapy for venous thromboembolism.
Monkman K; Lazo-Langner A; Kovacs MJ
Thromb Res; 2009 Jul; 124(3):275-80. PubMed ID: 19155056
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
[TBL] [Abstract][Full Text] [Related]
8. Practical application of the 10-mg warfarin initiation nomogram.
Wells PS; Le Gal G; Tierney S; Carrier M
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):403-8. PubMed ID: 19521238
[TBL] [Abstract][Full Text] [Related]
9. Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease.
Kovacs MJ; Cruickshank M; Wells PS; Kim H; Chin-Yee I; Morrow B; Boyle E; Kovacs J
Haemostasis; 1998; 28(2):62-9. PubMed ID: 10087430
[TBL] [Abstract][Full Text] [Related]
10. Outpatient treatment of community acquired venous thromboembolism--the Christchurch experience.
Heaton D; Han DY; Inder A
N Z Med J; 2002 Jul; 115(1158):U105. PubMed ID: 12362180
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 10-mg and 5-mg warfarin initiation nomograms in a South Indian population - An open label trial.
Naik D S; Pillai VM; Adole PS
Thromb Res; 2019 Apr; 176():33-35. PubMed ID: 30772640
[TBL] [Abstract][Full Text] [Related]
13. The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis.
Ageno W; Steidl L; Ultori C; Dentali F; Marchesi C; Mera V; Squizzato A; Venco A
Blood Coagul Fibrinolysis; 2003 Jan; 14(1):11-4. PubMed ID: 12544722
[TBL] [Abstract][Full Text] [Related]
14. Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
Le Gal G; Carrier M; Tierney S; Majeed H; Rodger M; Wells PS
J Thromb Haemost; 2010 Jan; 8(1):90-4. PubMed ID: 19874475
[TBL] [Abstract][Full Text] [Related]
15. The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.
Deerhake JP; Merz JC; Cooper JV; Eagle KA; Fay WP
J Thromb Thrombolysis; 2007 Apr; 23(2):107-13. PubMed ID: 17221327
[TBL] [Abstract][Full Text] [Related]
16. [Warfarin treatment of venous thromboembolism].
Andersen IA; Hammerstrøm J
Tidsskr Nor Laegeforen; 2002 Apr; 122(10):1012-6. PubMed ID: 12082693
[TBL] [Abstract][Full Text] [Related]
17. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
[TBL] [Abstract][Full Text] [Related]
18. Warfarin therapy in the HIV medical home model: low rates of therapeutic anticoagulation despite adherence and differences in dosing based on specific antiretrovirals.
Anderson AM; Chane T; Patel M; Chen S; Xue W; Easley KA
AIDS Patient Care STDS; 2012 Aug; 26(8):454-62. PubMed ID: 22742455
[TBL] [Abstract][Full Text] [Related]
19. Initiating warfarin therapy: 5 mg versus 10 mg.
Eckhoff CD; Didomenico RJ; Shapiro NL
Ann Pharmacother; 2004 Dec; 38(12):2115-21. PubMed ID: 15522981
[TBL] [Abstract][Full Text] [Related]
20. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
Larson BJ; Zumberg MS; Kitchens CS
Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
